Inflammatory biomarker – Page 11 – Communicable Diseases Research

New Insights in Laboratory Testing for COVID-19 Patients: Looking for the Role and Predictive Value of Human epididymis secretory protein 4 (HE4) and the Innate Immunity of the Oral Cavity and Respiratory Tract

Article

Published on 2020-11-022022-10-29
Journal: Microorganisms [Category] COVID-19,

Characterization of Myocardial Injury in Patients With COVID-19

Research article

Published on 2020-11-012022-10-05
Journal: Journal of the American College of Cardiology [Category] SARS, 바이오마커,

SARS-CoV-2 RapidPlex: A Graphene-Based Multiplexed Telemedicine Platform for Rapid and Low-Cost COVID-19 Diagnosis and Monitoring

Research article

Published on 2020-10-052022-10-05
Journal: Matter [Category] 바이오마커, 치료기술,

Characteristics and Outcomes of Recipients of Heart Transplant With Coronavirus Disease 2019

2019년 코로나바이러스로 심장 이식 환자의 특성 및 결과

Article

Published on 2020-10-012022-09-11
Journal: JAMA Cardiology [Category] Fulltext, MERS, 바이오마커,

[키워드] Administered adverse outcome adverse outcomes analyses antagonist approach C-reactive protein calcineurin cardiac allograft Case fatality rate Case series case sery change Characteristics clinically comorbid conditions condition coronavirus disease Coronavirus disease 2019 Corticosteroid Corticosteroids COVID-19 COVID-19 infection diabete diabetes diagnosis of COVID-19 died discharged home dose elevated evaluate Evidence evidence of Fatality rate Follow-up heart High-dose High-sensitivity C-reactive protein Hospitalization Hospitalized Hydroxychloroquine hypertension Immunosuppression increased risk Infection Inflammatory biomarker inhibitor interleukin interleukin 6 interleukin 6 receptor interquartile range IQR Laboratory laboratory analyses management measure mechanical ventilation median median age median time men MOST multiple comorbidities multiple comorbidity mycophenolate mycophenolate mofetil myocardial injury New York outcome participant Patient patients receptor antagonists recipient recipients reduction in required secondary single-center the median Transplant Treatment treatment of COVID-19 troponin T Vasculopathy vital status was reduced were infected with COVID-19
[DOI] 10.1001/jamacardio.2020.2159 PMC 바로가기 [Article Type] Article

Do free radical NETwork and oxidative stress disparities in African Americans enhance their vulnerability to SARS-CoV-2 infection and COVID-19 severity?

아프리카 계 미국인의 자유 라디칼 네트워크 및 산화 스트레스 불균형이 SARS-CoV-2 감염 및 COVID-19 심각성에 대한 취약성을 강화합니까?

Review

Published on 2020-10-012022-09-11
Journal: Redox Biology [Category] SARS, 신약개발,

[키워드] African African American African Americans amplifying Autoimmune autoimmune and inflammatory diseases Bacteria black Black Americans Care cells Comorbidities Comorbidity Complication contribute coronavirus COVID-19 COVID-19 patient COVID-19 patients COVID-19 severity Critical deaths decrease diabetes disease severity Diseases drug elevated ENhance Factor free radical Free radicals fungi Health Health care host cells hyper-inflammation hypertension hypothetical identifying immune cells individual infected with SARS-CoV-2 Inflammation Inflammatory biomarker inflammatory disease Inflammatory diseases inhibiting killing lack mechanism mice mitigate Mortality NET NETs neutrophil Neutrophil extracellular trap Neutrophil extracellular traps Neutrophils obesity Oxidant oxidants Oxidants. oxidative stress pathogen Pathogens preventive measure preventive measures pro-inflammatory PROTECT SARS-CoV-2 SARS-COV-2 infection socioeconomic status Treatment viruses Vitamin
[DOI] 10.1016/j.redox.2020.101721 PMC 바로가기 [Article Type] Review

Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019 The GRECCO-19 Randomized Clinical Trial

코로나바이러스 질병 2019로 입원한 환자의 심장 및 염증성 바이오마커와 임상 결과에 대한 콜히친 대 표준 치료의 효과 GRECCO-19 무작위 임상 시험

Research

Published on 2020-06-242022-08-13
Journal: JAMA Network Open [Category] SARS, 임상,

[키워드] 1:1 105 patient 105 patients 95% CI activity acute respiratory syndrome administration Adverse adverse events age all-cause mortality anti-inflammatory action biochemical C-reactive protein cardiac cardiac troponin caution clinical clinical benefit Clinical deterioration clinical end point Clinical outcome clinical outcomes clinical status clinical trial Colchicine colchicine group Complication Concentration control group coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 death Deterioration diarrhea dimerized Effect effect of treatment efficacy analysis end point evaluate evaluate the effect evaluated event except for finding followed by global pandemic Greece groups hospital Hospitalized Identifier Importance increase in Infection Inflammatory biomarker intention-to-treat basis interquartile range Loading dose log rank maintenance dose measure mechanical ventilation median no difference no significant difference no significant differences normal activities objective Odds ratio Open-label participant Patient patients patients hospitalized plasma fragment D Point prevention primary end point Randomized randomized clinical trial receipt Registration Relevance respiratory Result safety profile secondary seriousness setting severity significant differences significantly Standard statistically survival survival time symptomatic took place treat Treatment treatment with colchicine Trial registration troponin was performed with COVID-19
[DOI] 10.1001/jamanetworkopen.2020.13136 PMC 바로가기 [Article Type] Research

A Genome-Wide Association Scan on the Levels of Markers of Inflammation in Sardinians Reveals Associations That Underpin Its Complex Regulation

사르데냐인의 염증 표지자 수준에 대한 게놈 전체의 연관성 스캔은 복잡한 조절을 뒷받침하는 연관성을 보여줍니다

Research Article

Published on 2012-01-262022-09-06
Journal: PLoS Genetics [Category] Communicable Disease,

[키워드] ABO gene AIRE APOC-I approach association associations Author autosomal C-reactive protein CADM3 CCR2 Cohort common disease complex conducted CR1 CRP CRP gene damaged cells DARC detect different different diseases Effects erythrocyte sedimentation erythrocyte sedimentation rate ESR Evidence Factor found functional Gene genetic determinant genetic determinants Genetic variant genetic variants genome-wide association scan Genome-wide association scans genome-wide significant genotyped GWAS HBB Health help High-sensitivity C-reactive protein highlight HNF1A hsCRP ICOSLG identifying IL-6 IL-6R gene ImmunoChip implicated IMPROVE included independent individual individuals Inflammation inflammation erythrocyte sedimentation rate Inflammatory biomarker interleukin interleukin-6 knowledge large cohort led to Level loci MCP-1 mechanism MetaboChip custom arrays molecular mechanism molecular mechanisms monocyte monocyte chemotactic protein-1 novel organism performed power pro-inflammatory molecule pro-inflammatory molecules Protective Protein provided QTLs Quantitative quantitative traits receptor Regulation replicated robust rs113459440 rs11829037 rs1205 rs12075 rs12567990 rs17141006 rs225918 rs3026968 rs3093077 rs3845624 rs4129267 rs4420638 rs4910472 rs657152 Sardinia Sardinian sedimentation rate selected SNP SPPL3 TMEM57 UCN119B UNC119B variant X chromosome SNP
[DOI] 10.1371/journal.pgen.1002480 PMC 바로가기 [Article Type] Research Article